An in vivo cardiac assay to determine the functional consequences of putative long qt syndrome mutations: Short communication

Circulation Research

Volumn 112, Issue 5, 2013, Pages 826-830

  Jou, Chuanchau J ^a   Barnett, Spencer M ^a   Bian, Jian Tao ^a   Weng, H Cindy ^a   Sheng, Xiaoming ^a   Tristani Firouzi, Martin ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

arrhythmia; channelopathy; gene mutation; genetic testing; genetics polymorphism; ion channels; long QT syndrome; model organism; sudden death

Indexed keywords

POTASSIUM CHANNEL HERG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE MUTATION; GENE SILENCING; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; HEART REPOLARIZATION; HIGH THROUGHPUT SEQUENCING; IN VIVO STUDY; LONG QT SYNDROME; NONHUMAN; PREDICTIVE VALUE; PRIORITY JOURNAL;

ALGORITHMS; ANIMALS; DISEASE MODELS, ANIMAL; ETHER-A-GO-GO POTASSIUM CHANNELS; GENE KNOCKDOWN TECHNIQUES; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HEART; HIGH-THROUGHPUT SCREENING ASSAYS; LONG QT SYNDROME; MUTATION; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84874762615     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.112.300664     Document Type: Article

References (15)

1. Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL, Moss AJ, Schwartz PJ, Towbin JA, Vincent GM, Keating MT. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation. 2000;102:1178-1185.
2. Tester DJ, Will ML, Haglund CM, Ackerman MJ. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm. 2005;2:507-517.
3. Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8:1308-1339.
4. Ashley EA, Hershberger RE, Caleshu C, et al.; American Heart Association Advocacy Coordinating Committee. Genetics and cardiovascular disease: a policy statement from the American Heart Association. Circulation. 2012;126:142-157.
5. Kopp R, Schwerte T, Pelster B. Cardiac performance in the zebrafish breakdance mutant. J Exp Biol. 2005;208:2123-2134.
6. Milan DJ, Jones IL, Ellinor PT, MacRae CA. In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation. Am J Physiol Heart Circ Physiol. 2006;291:H269-H273.
7. Arnaout R, Ferrer T, Huisken J, Spitzer K, Stainier DY, Tristani-Firouzi M, Chi NC. Zebrafish model for human long QT syndrome. Proc Natl Acad Sci USA. 2007;104:11316-11321.
8. Langheinrich U, Vacun G, Wagner T. Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QTprolonging drugs inducing severe arrhythmia. Toxicol Appl Pharmacol. 2003;193:370-382.
9. Zhou Z, Gong Q, Epstein ML, January CT. HERG channel dysfunction in human long QT syndrome. Intracellular transport and functional defects. J Biol Chem. 1998;273:21061-21066.
10. Zhang X, Chen S, Zhang L, Liu M, Redfearn S, Bryant RM, Oberti C, Vincent GM, Wang QK. Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and identification of novel KCNQ1 and KCNH2 mutations. BMC Med Genet. 2008;9:87.
11. Priori SG, Napolitano C, Schwartz PJ. Low penetrance in the long-QT syndrome: clinical impact. Circulation. 1999;99:529-533.
12. Anderson CL, Delisle BP, Anson BD, Kilby JA, Will ML, Tester DJ, Gong Q, Zhou Z, Ackerman MJ, January CT. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism. Circulation. 2006;113:365-373.
13. Refsgaard L, Holst AG, Sadjadieh G, Haunsø S, Nielsen JB, Olesen MS. High prevalence of genetic variants previously associated with LQT syndrome in new exome data. Eur J Hum Genet. 2012;20:905-908.
14. Landstrom AP, Ackerman MJ. The Achilles' heel of cardiovascular genetic testing: distinguishing pathogenic mutations from background genetic noise. Clin Pharmacol Ther. 2011;90:496-499.
15. Giudicessi JR, Kapplinger JD, Tester DJ, Alders M, Salisbury BA, Wilde AA, Ackerman MJ. Phylogenetic and physicochemical analyses enhance the classification of rare nonsynonymous single nucleotide variants in type 1 and 2 long-QT syndrome. Circ Cardiovasc Genet. 2012;5:519-528.